Brendan Smith

Stock Analyst at TD Cowen

(1.14)
# 3,450
Out of 4,786 analysts
6
Total ratings
40%
Success rate
-3.69%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Brendan Smith

Ginkgo Bioworks Holdings
Sep 20, 2024
Maintains: Buy
Price Target: $3$10
Current: $5.70
Upside: +75.44%
Halozyme Therapeutics
Aug 7, 2024
Maintains: Buy
Price Target: $59$65
Current: $63.81
Upside: +1.86%
Novavax
May 13, 2024
Maintains: Hold
Price Target: $5$10
Current: $6.41
Upside: +56.01%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $12.74
Upside: -
Denali Therapeutics
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $13.60
Upside: -